FDA Introduces ‘Chain of Risk’ Framework to Advance Tobacco Harm Reduction

As global regulators rethink tobacco control strategies, the U.S. FDA’s move toward a “chain of risk” framework has sparked fresh debate on harm reduction. To understand its implications for India, we spoke to Dr. Sanjeev Gera, Senior Director & HOD, Interventional Cardiology, Fortis Hospital, Noida, UP. He shared insights on why a harm-reduction-led approach could complement India’s existing tobacco control policies and improve public health outcomes